Sanofi Consumer Healthcare India (SCHIL) has officially marked a significant milestone with its listing on BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE).
The company in a press statement on Friday informed that its equity shares were symbolically launched through the ringing of the opening bell at the BSE by Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India.
Commenting on this achievement, Bakshi said, "India’s consumer healthcare market has vast potential. SCHIL’s listing on BSE and NSE marks a critical milestone for us, further strengthening our position and driving sustainable growth within the Indian market. By evaluating our business needs, capitalising on emerging consumer trends in healthcare, and fostering a culture of digital innovation, we aim to address unmet consumer needs and enhance customer experiences with our products."
Bakshi further added, "We remain committed to our mission of making self-care as simple as it should be, empowering consumers to take control of their health. I am confident that our consumer-first approach will drive our ambition to build the best Fast-Moving Consumer Healthcare (FMCH) organisation in and for the world."
SCHIL emerged as a distinct legal entity following its demerger from Sanofi India, effective from 1st June 2024. The demerger was executed under the Scheme of Arrangement sanctioned by the Mumbai bench of the National Company Law Tribunal. Now operating independently, SCHIL is fully aligned with Sanofi’s global strategy and remains focused on the Consumer Healthcare sector, with a commitment to high standards of ethics, marketing practices, and business operations, the press statement added.
_20241226144814_original_image_13.webp)
_20241227161542_original_image_22.webp)
